BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2119262)

  • 1. Polycyclic aromatic hydrocarbon-DNA adducts in lung tissue from lung cancer patients.
    van Schooten FJ; Hillebrand MJ; van Leeuwen FE; Lutgerink JT; van Zandwijk N; Jansen HM; Kriek E
    Carcinogenesis; 1990 Sep; 11(9):1677-81. PubMed ID: 2119262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycyclic aromatic hydrocarbon--DNA adducts in white blood cells from lung cancer patients: no correlation with adduct levels in lung.
    van Schooten FJ; Hillebrand MJ; van Leeuwen FE; van Zandwijk N; Jansen HM; den Engelse L; Kriek E
    Carcinogenesis; 1992 Jun; 13(6):987-93. PubMed ID: 1600621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of 32P-postlabelling and immunological methods to examine human lung DNA for benzo[a]pyrene adducts.
    Garner RC; Tierney B; Phillips DH
    IARC Sci Publ; 1988; (89):196-200. PubMed ID: 3143669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The binding efficiency of polyclonal and monoclonal antibodies to DNA modified with benzo[a]pyrene diol epoxide is dependent on the level of modification. Implications for quantitation of benzo[a]pyrene-DNA adducts in vivo.
    Van Schooten FJ; Kriek E; Steenwinkel MJ; Noteborn HP; Hillebrand MJ; Van Leeuwen FE
    Carcinogenesis; 1987 Sep; 8(9):1263-9. PubMed ID: 3113753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoaffinity concentration of human lung DNA adducts using an anti-benzo[a]pyrene-diol-epoxide-DNA antibody. Analysis by 32P-postlabelling or ELISA.
    King MM; Cuzick J; Jenkins D; Routledge MN; Garner RC
    Mutat Res; 1993 Oct; 292(2):113-22. PubMed ID: 7692247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a new fluorometric assay for benzo[a]pyrene diolepoxide-DNA adducts in human white blood cells: comparisons with 32P-postlabeling and ELISA.
    Rojas M; Alexandrov K; van Schooten FJ; Hillebrand M; Kriek E; Bartsch H
    Carcinogenesis; 1994 Mar; 15(3):557-60. PubMed ID: 8118943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay.
    Gyorffy E; Anna L; Gyori Z; Segesdi J; Minárovits J; Soltész I; Kostic S; Csekeo A; Poirier MC; Schoket B
    Carcinogenesis; 2004 Jul; 25(7):1201-9. PubMed ID: 15001535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of polycyclic aromatic hydrocarbon-DNA adducts in human lung.
    Weston A; Bowman ED; Shields PG; Trivers GE; Poirier MC; Santella RM; Manchester DK
    Environ Health Perspect; 1993 Mar; 99():257-9. PubMed ID: 8319638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of benzo[a]pyrene diol epoxide-DNA adducts in white blood cell DNA from coke-oven workers: the impact of smoking.
    van Schooten FJ; van Leeuwen FE; Hillebrand MJ; de Rijke ME; Hart AA; van Veen HG; Oosterink S; Kriek E
    J Natl Cancer Inst; 1990 Jun; 82(11):927-33. PubMed ID: 2111410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of optimal conditions for the detection of benzo[a]pyrene-DNA adducts by enzyme-linked immunoadsorbent assays (ELISA).
    Bucci F; Galati R; Zito R; Falasca G; Federico A; Verdina A
    Anticancer Res; 1998; 18(4A):2669-74. PubMed ID: 9703926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative synchronous fluorescence spectrophotometry and 32P-postlabeling analysis of PAH-DNA adducts in human lung and the relationship to TP53 mutations.
    Andreassen A; Kure EH; Nielsen PS; Autrup H; Haugen A
    Mutat Res; 1996 Jul; 368(3-4):275-82. PubMed ID: 8692233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An improved fluorometric assay for dosimetry of benzo(a)pyrene diol-epoxide-DNA adducts in smokers' lung: comparisons with total bulky adducts and aryl hydrocarbon hydroxylase activity.
    Alexandrov K; Rojas M; Geneste O; Castegnaro M; Camus AM; Petruzzelli S; Giuntini C; Bartsch H
    Cancer Res; 1992 Nov; 52(22):6248-53. PubMed ID: 1423269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of (7S,8R)-dihydroxy-(9R,10S)-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene adducts in human serum albumin by laser-induced fluorescence: implications for the in vivo metabolism of benzo[a]pyrene.
    Ozbal CC; Skipper PL; Yu MC; London SJ; Dasari RR; Tannenbaum SR
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):733-9. PubMed ID: 10919745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of DNA adducts and sister chromatid exchange in lung cancer cases and controls.
    Perera F; Mayer J; Jaretzki A; Hearne S; Brenner D; Young TL; Fischman HK; Grimes M; Grantham S; Tang MX
    Cancer Res; 1989 Aug; 49(16):4446-51. PubMed ID: 2743334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of benzo[a]pyrene-DNA adducts in cultured cells treated with benzo[a]pyrene diol-epoxide by quantitative immunofluorescence microscopy and 32P-postlabelling; immunofluorescence analysis of benzo[a]pyrene-DNA adducts in bronchial cells from smoking individuals.
    Baan RA; van den Berg PT; Steenwinkel MJ; van der Wulp CJ
    IARC Sci Publ; 1988; (89):146-54. PubMed ID: 3143666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-performance liquid chromatography electrospray ionization tandem mass spectrometry for the detection and quantitation of benzo[a]pyrene-DNA adducts.
    Beland FA; Churchwell MI; Von Tungeln LS; Chen S; Fu PP; Culp SJ; Schoket B; Gyorffy E; Minárovits J; Poirier MC; Bowman ED; Weston A; Doerge DR
    Chem Res Toxicol; 2005 Aug; 18(8):1306-15. PubMed ID: 16097804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPLC/fluorescence determination of anti-BPDE-DNA adducts in mononuclear white blood cells from PAH-exposed humans.
    Pavanello S; Favretto D; Brugnone F; Mastrangelo G; Dal Pra G; Clonfero E
    Carcinogenesis; 1999 Mar; 20(3):431-5. PubMed ID: 10190558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical visualization of DNA adducts in mouse tissues and human white blood cells following treatment with benzo[a]pyrene or its diol epoxide. A quantitative approach.
    van Schooten FJ; Hillebrand MJ; Scherer E; den Engelse L; Kriek E
    Carcinogenesis; 1991 Mar; 12(3):427-33. PubMed ID: 1901249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of benzo[a]pyrene 7,8-diol 9,10-epoxide N2-deoxyguanosine in human lung adenocarcinoma cells exposed to cooking oil fumes from frying fish under domestic conditions.
    Yang SC; Jenq SN; Kang ZC; Lee H
    Chem Res Toxicol; 2000 Oct; 13(10):1046-50. PubMed ID: 11080053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High DNA damage by benzo[a]pyrene 7,8-diol-9,10-epoxide in bronchial epithelial cells from patients with lung cancer: comparison with lung parenchyma.
    Rojas M; Marie B; Vignaud JM; Martinet N; Siat J; Grosdidier G; Cascorbi I; Alexandrov K
    Cancer Lett; 2004 Apr; 207(2):157-63. PubMed ID: 15072824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.